Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
Richard J. Gralla(American Society of Clinical Oncology), David G. Pfister(Memorial Sloan Kettering Cancer Center), David P. Gill(American Society of Clinical Oncology), Paul J. Hesketh(American Society of Clinical Oncology), Mark G. Kris(American Society of Clinical Oncology), Lawrence W. Chinnery(American Society of Clinical Oncology), Gary R. Morrow(University of Rochester Medical Center), Edith A. Perez(Jacksonville College), Rebecca Clark-Snow(American Society of Clinical Oncology), Susan Groshen(American Society of Clinical Oncology), Jeffrey H. Silber(American Society of Clinical Oncology), Peter Kirkbride(American Society of Clinical Oncology), Steven M. Grunberg(American Society of Clinical Oncology), David Osoba, James M. Koeller(American Society of Clinical Oncology)
Cited by 670
Related Papers
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology
|JNCI Journal of the National Cancer Institute|1993|15.9k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k